Cargando…
Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice
Patients in the chronic phase (CP) of chronic myelogenous leukemia (CML) have been treated successfully following the advent of ABL kinase inhibitors, but once they progress to the blast crisis (BC) phase the prognosis becomes dismal. Although mechanisms underlying the progression are largely unknow...
Autores principales: | Yamamoto, Kiyoko, Tsuzuki, Shinobu, Minami, Yosuke, Yamamoto, Yukiya, Abe, Akihiro, Ohshima, Koichi, Seto, Masao, Naoe, Tomoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787010/ https://www.ncbi.nlm.nih.gov/pubmed/24098673 http://dx.doi.org/10.1371/journal.pone.0074864 |
Ejemplares similares
-
Isoform-Specific Potentiation of Stem and Progenitor Cell Engraftment by AML1/RUNX1
por: Tsuzuki, Shinobu, et al.
Publicado: (2007) -
Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia
por: Ma, Cheng-Cheng, et al.
Publicado: (2020) -
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
por: Ross, Theodora S, et al.
Publicado: (2014) -
Quantification of BCR-ABL mRNA in Plasma/Serum of Patients with Chronic Myelogenous Leukemia
por: Narita, Miwako, et al.
Publicado: (2012) -
Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia
por: Hai, Abdul, et al.
Publicado: (2014)